aluates Reports

$ 0.0

Automative

Global Blood Pressure Disorders Drug Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-5U6054

Global Blood Pressure Disorders Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Blood Pressure Disorders Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-5U6054

Report

December 2024

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Blood Pressure Disorders Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Blood Pressure Disorders Drug Market

Blood pressure disorder drug development technology and related units

Market Analysis and Insights: Global Blood Pressure Disorders Drug Market

The global Blood Pressure Disorders Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Blood Pressure Disorders Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Blood Pressure Disorders Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Blood Pressure Disorders Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Pressure Disorders Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Blood Pressure Disorders Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Blood Pressure Disorders Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Blood Pressure Disorders Drug Market Report

Report Metric	Details
Report Name	Blood Pressure Disorders Drug Market
CAGR	5%
Segment by Type	Diuretics Angiotensin Converting Enzyme (ACE) Inhibitors Angiotensin Receptor Blockers (ARBs) Others
Segment by Application	Hypertension Hypotension Pulmonary Hypertension
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Blood Pressure Disorders Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Pressure Disorders Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Pressure Disorders Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Blood Pressure Disorders Drug Market report?

Ans: The main players in the Blood Pressure Disorders Drug Market are A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl

What are the Application segmentation covered in the Blood Pressure Disorders Drug Market report?

Ans: The Applications covered in the Blood Pressure Disorders Drug Market report are Hypertension, Hypotension, Pulmonary Hypertension

What are the Type segmentation covered in the Blood Pressure Disorders Drug Market report?

Ans: The Types covered in the Blood Pressure Disorders Drug Market report are Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Diuretics

1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors

1.2.4 Angiotensin Receptor Blockers (ARBs)

1.2.5 Others

1.3 Market by Application

1.3.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hypertension

1.3.3 Hypotension

1.3.4 Pulmonary Hypertension

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood Pressure Disorders Drug Market Perspective (2019-2030)

2.2 Global Blood Pressure Disorders Drug Growth Trends by Region

2.2.1 Blood Pressure Disorders Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Blood Pressure Disorders Drug Historic Market Size by Region (2019-2024)

2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Region (2025-2030)

2.3 Blood Pressure Disorders Drug Market Dynamics

2.3.1 Blood Pressure Disorders Drug Industry Trends

2.3.2 Blood Pressure Disorders Drug Market Drivers

2.3.3 Blood Pressure Disorders Drug Market Challenges

2.3.4 Blood Pressure Disorders Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Blood Pressure Disorders Drug by Players

3.1.1 Global Blood Pressure Disorders Drug Revenue by Players (2019-2024)

3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2019-2024)

3.2 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Blood Pressure Disorders Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Blood Pressure Disorders Drug Market Concentration Ratio

3.4.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2023

3.5 Global Key Players of Blood Pressure Disorders Drug Head office and Area Served

3.6 Global Key Players of Blood Pressure Disorders Drug, Product and Application

3.7 Global Key Players of Blood Pressure Disorders Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Pressure Disorders Drug Breakdown Data by Type

4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2019-2024)

4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2025-2030)

5 Blood Pressure Disorders Drug Breakdown Data by Application

5.1 Global Blood Pressure Disorders Drug Historic Market Size by Application (2019-2024)

5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Blood Pressure Disorders Drug Market Size (2019-2030)

6.2 North America Blood Pressure Disorders Drug Market Size by Type

6.2.1 North America Blood Pressure Disorders Drug Market Size by Type (2019-2024)

6.2.2 North America Blood Pressure Disorders Drug Market Size by Type (2025-2030)

6.2.3 North America Blood Pressure Disorders Drug Market Share by Type (2019-2030)

6.3 North America Blood Pressure Disorders Drug Market Size by Application

6.3.1 North America Blood Pressure Disorders Drug Market Size by Application (2019-2024)

6.3.2 North America Blood Pressure Disorders Drug Market Size by Application (2025-2030)

6.3.3 North America Blood Pressure Disorders Drug Market Share by Application (2019-2030)

6.4 North America Blood Pressure Disorders Drug Market Size by Country

6.4.1 North America Blood Pressure Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Blood Pressure Disorders Drug Market Size by Country (2019-2024)

6.4.3 North America Blood Pressure Disorders Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Blood Pressure Disorders Drug Market Size (2019-2030)

7.2 Europe Blood Pressure Disorders Drug Market Size by Type

7.2.1 Europe Blood Pressure Disorders Drug Market Size by Type (2019-2024)

7.2.2 Europe Blood Pressure Disorders Drug Market Size by Type (2025-2030)

7.2.3 Europe Blood Pressure Disorders Drug Market Share by Type (2019-2030)

7.3 Europe Blood Pressure Disorders Drug Market Size by Application

7.3.1 Europe Blood Pressure Disorders Drug Market Size by Application (2019-2024)

7.3.2 Europe Blood Pressure Disorders Drug Market Size by Application (2025-2030)

7.3.3 Europe Blood Pressure Disorders Drug Market Share by Application (2019-2030)

7.4 Europe Blood Pressure Disorders Drug Market Size by Country

7.4.1 Europe Blood Pressure Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Blood Pressure Disorders Drug Market Size by Country (2019-2024)

7.4.3 Europe Blood Pressure Disorders Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Blood Pressure Disorders Drug Market Size (2019-2030)

8.2 China Blood Pressure Disorders Drug Market Size by Type

8.2.1 China Blood Pressure Disorders Drug Market Size by Type (2019-2024)

8.2.2 China Blood Pressure Disorders Drug Market Size by Type (2025-2030)

8.2.3 China Blood Pressure Disorders Drug Market Share by Type (2019-2030)

8.3 China Blood Pressure Disorders Drug Market Size by Application

8.3.1 China Blood Pressure Disorders Drug Market Size by Application (2019-2024)

8.3.2 China Blood Pressure Disorders Drug Market Size by Application (2025-2030)

8.3.3 China Blood Pressure Disorders Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Blood Pressure Disorders Drug Market Size (2019-2030)

9.2 Asia Blood Pressure Disorders Drug Market Size by Type

9.2.1 Asia Blood Pressure Disorders Drug Market Size by Type (2019-2024)

9.2.2 Asia Blood Pressure Disorders Drug Market Size by Type (2025-2030)

9.2.3 Asia Blood Pressure Disorders Drug Market Share by Type (2019-2030)

9.3 Asia Blood Pressure Disorders Drug Market Size by Application

9.3.1 Asia Blood Pressure Disorders Drug Market Size by Application (2019-2024)

9.3.2 Asia Blood Pressure Disorders Drug Market Size by Application (2025-2030)

9.3.3 Asia Blood Pressure Disorders Drug Market Share by Application (2019-2030)

9.4 Asia Blood Pressure Disorders Drug Market Size by Region

9.4.1 Asia Blood Pressure Disorders Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Blood Pressure Disorders Drug Market Size by Region (2019-2024)

9.4.3 Asia Blood Pressure Disorders Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 A1M Pharma AB

11.1.1 A1M Pharma AB Company Details

11.1.2 A1M Pharma AB Business Overview

11.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction

11.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.1.5 A1M Pharma AB Recent Developments

11.2 Acceleron Pharma Inc

11.2.1 Acceleron Pharma Inc Company Details

11.2.2 Acceleron Pharma Inc Business Overview

11.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction

11.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.2.5 Acceleron Pharma Inc Recent Developments

11.3 Ache Laboratorios Farmaceuticos SA

11.3.1 Ache Laboratorios Farmaceuticos SA Company Details

11.3.2 Ache Laboratorios Farmaceuticos SA Business Overview

11.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction

11.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.3.5 Ache Laboratorios Farmaceuticos SA Recent Developments

11.4 Actelion Pharmaceuticals Ltd

11.4.1 Actelion Pharmaceuticals Ltd Company Details

11.4.2 Actelion Pharmaceuticals Ltd Business Overview

11.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction

11.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.4.5 Actelion Pharmaceuticals Ltd Recent Developments

11.5 Aerogen Ltd

11.5.1 Aerogen Ltd Company Details

11.5.2 Aerogen Ltd Business Overview

11.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction

11.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.5.5 Aerogen Ltd Recent Developments

11.6 Anavex Life Sciences Corp

11.6.1 Anavex Life Sciences Corp Company Details

11.6.2 Anavex Life Sciences Corp Business Overview

11.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction

11.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.6.5 Anavex Life Sciences Corp Recent Developments

11.7 AnGes Inc

11.7.1 AnGes Inc Company Details

11.7.2 AnGes Inc Business Overview

11.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction

11.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.7.5 AnGes Inc Recent Developments

11.8 Arena Pharmaceuticals Inc

11.8.1 Arena Pharmaceuticals Inc Company Details

11.8.2 Arena Pharmaceuticals Inc Business Overview

11.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction

11.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.8.5 Arena Pharmaceuticals Inc Recent Developments

11.9 Ascendia Pharmaceuticals LLC

11.9.1 Ascendia Pharmaceuticals LLC Company Details

11.9.2 Ascendia Pharmaceuticals LLC Business Overview

11.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction

11.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.9.5 Ascendia Pharmaceuticals LLC Recent Developments

11.10 Ascendis Pharma A/S

11.10.1 Ascendis Pharma A/S Company Details

11.10.2 Ascendis Pharma A/S Business Overview

11.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction

11.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.10.5 Ascendis Pharma A/S Recent Developments

11.11 AVEO Pharmaceuticals Inc

11.11.1 AVEO Pharmaceuticals Inc Company Details

11.11.2 AVEO Pharmaceuticals Inc Business Overview

11.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction

11.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.11.5 AVEO Pharmaceuticals Inc Recent Developments

11.12 Bayer AG

11.12.1 Bayer AG Company Details

11.12.2 Bayer AG Business Overview

11.12.3 Bayer AG Blood Pressure Disorders Drug Introduction

11.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.12.5 Bayer AG Recent Developments

11.13 Bial - Portela & Ca SA

11.13.1 Bial - Portela & Ca SA Company Details

11.13.2 Bial - Portela & Ca SA Business Overview

11.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Introduction

11.13.4 Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.13.5 Bial - Portela & Ca SA Recent Developments

11.14 Bioblue Technologies Inc

11.14.1 Bioblue Technologies Inc Company Details

11.14.2 Bioblue Technologies Inc Business Overview

11.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction

11.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.14.5 Bioblue Technologies Inc Recent Developments

11.15 Biogen Inc

11.15.1 Biogen Inc Company Details

11.15.2 Biogen Inc Business Overview

11.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction

11.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.15.5 Biogen Inc Recent Developments

11.16 Biolab Farmaceutica Ltda

11.16.1 Biolab Farmaceutica Ltda Company Details

11.16.2 Biolab Farmaceutica Ltda Business Overview

11.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction

11.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.16.5 Biolab Farmaceutica Ltda Recent Developments

11.17 BioRestorative Therapies Inc

11.17.1 BioRestorative Therapies Inc Company Details

11.17.2 BioRestorative Therapies Inc Business Overview

11.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction

11.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.17.5 BioRestorative Therapies Inc Recent Developments

11.18 Boryung Pharmaceutical Co Ltd

11.18.1 Boryung Pharmaceutical Co Ltd Company Details

11.18.2 Boryung Pharmaceutical Co Ltd Business Overview

11.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction

11.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.18.5 Boryung Pharmaceutical Co Ltd Recent Developments

11.19 Bristol-Myers Squibb Co

11.19.1 Bristol-Myers Squibb Co Company Details

11.19.2 Bristol-Myers Squibb Co Business Overview

11.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction

11.19.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.19.5 Bristol-Myers Squibb Co Recent Developments

11.20 Camurus AB

11.20.1 Camurus AB Company Details

11.20.2 Camurus AB Business Overview

11.20.3 Camurus AB Blood Pressure Disorders Drug Introduction

11.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.20.5 Camurus AB Recent Developments

11.21 Capricor Therapeutics Inc

11.21.1 Capricor Therapeutics Inc Company Details

11.21.2 Capricor Therapeutics Inc Business Overview

11.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction

11.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.21.5 Capricor Therapeutics Inc Recent Developments

11.22 Celsion Corp

11.22.1 Celsion Corp Company Details

11.22.2 Celsion Corp Business Overview

11.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction

11.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.22.5 Celsion Corp Recent Developments

11.23 Celtaxsys Inc

11.23.1 Celtaxsys Inc Company Details

11.23.2 Celtaxsys Inc Business Overview

11.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction

11.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.23.5 Celtaxsys Inc Recent Developments

11.24 Chiesi Farmaceutici SpA

11.24.1 Chiesi Farmaceutici SpA Company Details

11.24.2 Chiesi Farmaceutici SpA Business Overview

11.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction

11.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.24.5 Chiesi Farmaceutici SpA Recent Developments

11.25 Chong Kun Dang Pharmaceutical Corp

11.25.1 Chong Kun Dang Pharmaceutical Corp Company Details

11.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview

11.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction

11.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.25.5 Chong Kun Dang Pharmaceutical Corp Recent Developments

11.26 Chugai Pharmaceutical Co Ltd

11.26.1 Chugai Pharmaceutical Co Ltd Company Details

11.26.2 Chugai Pharmaceutical Co Ltd Business Overview

11.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction

11.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.26.5 Chugai Pharmaceutical Co Ltd Recent Developments

11.27 CJ HealthCare Corp

11.27.1 CJ HealthCare Corp Company Details

11.27.2 CJ HealthCare Corp Business Overview

11.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction

11.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.27.5 CJ HealthCare Corp Recent Developments

11.28 Complexa Inc

11.28.1 Complexa Inc Company Details

11.28.2 Complexa Inc Business Overview

11.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction

11.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.28.5 Complexa Inc Recent Developments

11.29 Corion Biotech Srl

11.29.1 Corion Biotech Srl Company Details

11.29.2 Corion Biotech Srl Business Overview

11.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction

11.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2019-2024)

11.29.5 Corion Biotech Srl Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Diuretics

Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors

Table 4. Key Players of Angiotensin Receptor Blockers (ARBs)

Table 5. Key Players of Others

Table 6. Global Blood Pressure Disorders Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Blood Pressure Disorders Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Blood Pressure Disorders Drug Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Blood Pressure Disorders Drug Market Share by Region (2019-2024)

Table 10. Global Blood Pressure Disorders Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Blood Pressure Disorders Drug Market Share by Region (2025-2030)

Table 12. Blood Pressure Disorders Drug Market Trends

Table 13. Blood Pressure Disorders Drug Market Drivers

Table 14. Blood Pressure Disorders Drug Market Challenges

Table 15. Blood Pressure Disorders Drug Market Restraints

Table 16. Global Blood Pressure Disorders Drug Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Blood Pressure Disorders Drug Revenue Share by Players (2019-2024)

Table 18. Global Top Blood Pressure Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Pressure Disorders Drug as of 2023)

Table 19. Global Blood Pressure Disorders Drug Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Blood Pressure Disorders Drug Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Blood Pressure Disorders Drug, Headquarters and Area Served

Table 22. Global Key Players of Blood Pressure Disorders Drug, Product and Application

Table 23. Global Key Players of Blood Pressure Disorders Drug, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2019-2024)

Table 27. Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2025-2030)

Table 29. Global Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Blood Pressure Disorders Drug Revenue Share by Application (2019-2024)

Table 31. Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Blood Pressure Disorders Drug Revenue Share by Application (2025-2030)

Table 33. North America Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Blood Pressure Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Blood Pressure Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Blood Pressure Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Blood Pressure Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Blood Pressure Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Blood Pressure Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Blood Pressure Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Blood Pressure Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Blood Pressure Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Blood Pressure Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Blood Pressure Disorders Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Blood Pressure Disorders Drug Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Blood Pressure Disorders Drug Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size by Country (2025-2030) & (US$ Million)

Table 65. A1M Pharma AB Company Details

Table 66. A1M Pharma AB Business Overview

Table 67. A1M Pharma AB Blood Pressure Disorders Drug Product

Table 68. A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 69. A1M Pharma AB Recent Developments

Table 70. Acceleron Pharma Inc Company Details

Table 71. Acceleron Pharma Inc Business Overview

Table 72. Acceleron Pharma Inc Blood Pressure Disorders Drug Product

Table 73. Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 74. Acceleron Pharma Inc Recent Developments

Table 75. Ache Laboratorios Farmaceuticos SA Company Details

Table 76. Ache Laboratorios Farmaceuticos SA Business Overview

Table 77. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product

Table 78. Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 79. Ache Laboratorios Farmaceuticos SA Recent Developments

Table 80. Actelion Pharmaceuticals Ltd Company Details

Table 81. Actelion Pharmaceuticals Ltd Business Overview

Table 82. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product

Table 83. Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 84. Actelion Pharmaceuticals Ltd Recent Developments

Table 85. Aerogen Ltd Company Details

Table 86. Aerogen Ltd Business Overview

Table 87. Aerogen Ltd Blood Pressure Disorders Drug Product

Table 88. Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 89. Aerogen Ltd Recent Developments

Table 90. Anavex Life Sciences Corp Company Details

Table 91. Anavex Life Sciences Corp Business Overview

Table 92. Anavex Life Sciences Corp Blood Pressure Disorders Drug Product

Table 93. Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 94. Anavex Life Sciences Corp Recent Developments

Table 95. AnGes Inc Company Details

Table 96. AnGes Inc Business Overview

Table 97. AnGes Inc Blood Pressure Disorders Drug Product

Table 98. AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 99. AnGes Inc Recent Developments

Table 100. Arena Pharmaceuticals Inc Company Details

Table 101. Arena Pharmaceuticals Inc Business Overview

Table 102. Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Product

Table 103. Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 104. Arena Pharmaceuticals Inc Recent Developments

Table 105. Ascendia Pharmaceuticals LLC Company Details

Table 106. Ascendia Pharmaceuticals LLC Business Overview

Table 107. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product

Table 108. Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 109. Ascendia Pharmaceuticals LLC Recent Developments

Table 110. Ascendis Pharma A/S Company Details

Table 111. Ascendis Pharma A/S Business Overview

Table 112. Ascendis Pharma A/S Blood Pressure Disorders Drug Product

Table 113. Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 114. Ascendis Pharma A/S Recent Developments

Table 115. AVEO Pharmaceuticals Inc Company Details

Table 116. AVEO Pharmaceuticals Inc Business Overview

Table 117. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product

Table 118. AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 119. AVEO Pharmaceuticals Inc Recent Developments

Table 120. Bayer AG Company Details

Table 121. Bayer AG Business Overview

Table 122. Bayer AG Blood Pressure Disorders Drug Product

Table 123. Bayer AG Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 124. Bayer AG Recent Developments

Table 125. Bial - Portela & Ca SA Company Details

Table 126. Bial - Portela & Ca SA Business Overview

Table 127. Bial - Portela & Ca SA Blood Pressure Disorders Drug Product

Table 128. Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 129. Bial - Portela & Ca SA Recent Developments

Table 130. Bioblue Technologies Inc Company Details

Table 131. Bioblue Technologies Inc Business Overview

Table 132. Bioblue Technologies Inc Blood Pressure Disorders Drug Product

Table 133. Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 134. Bioblue Technologies Inc Recent Developments

Table 135. Biogen Inc Company Details

Table 136. Biogen Inc Business Overview

Table 137. Biogen Inc Blood Pressure Disorders Drug Product

Table 138. Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 139. Biogen Inc Recent Developments

Table 140. Biolab Farmaceutica Ltda Company Details

Table 141. Biolab Farmaceutica Ltda Business Overview

Table 142. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product

Table 143. Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 144. Biolab Farmaceutica Ltda Recent Developments

Table 145. BioRestorative Therapies Inc Company Details

Table 146. BioRestorative Therapies Inc Business Overview

Table 147. BioRestorative Therapies Inc Blood Pressure Disorders Drug Product

Table 148. BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 149. BioRestorative Therapies Inc Recent Developments

Table 150. Boryung Pharmaceutical Co Ltd Company Details

Table 151. Boryung Pharmaceutical Co Ltd Business Overview

Table 152. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product

Table 153. Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 154. Boryung Pharmaceutical Co Ltd Recent Developments

Table 155. Bristol-Myers Squibb Co Company Details

Table 156. Bristol-Myers Squibb Co Business Overview

Table 157. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product

Table 158. Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 159. Bristol-Myers Squibb Co Recent Developments

Table 160. Camurus AB Company Details

Table 161. Camurus AB Business Overview

Table 162. Camurus AB Blood Pressure Disorders Drug Product

Table 163. Camurus AB Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 164. Camurus AB Recent Developments

Table 165. Capricor Therapeutics Inc Company Details

Table 166. Capricor Therapeutics Inc Business Overview

Table 167. Capricor Therapeutics Inc Blood Pressure Disorders Drug Product

Table 168. Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 169. Capricor Therapeutics Inc Recent Developments

Table 170. Celsion Corp Company Details

Table 171. Celsion Corp Business Overview

Table 172. Celsion Corp Blood Pressure Disorders Drug Product

Table 173. Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 174. Celsion Corp Recent Developments

Table 175. Celtaxsys Inc Company Details

Table 176. Celtaxsys Inc Business Overview

Table 177. Celtaxsys Inc Blood Pressure Disorders Drug Product

Table 178. Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 179. Celtaxsys Inc Recent Developments

Table 180. Chiesi Farmaceutici SpA Company Details

Table 181. Chiesi Farmaceutici SpA Business Overview

Table 182. Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Product

Table 183. Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 184. Chiesi Farmaceutici SpA Recent Developments

Table 185. Chong Kun Dang Pharmaceutical Corp Company Details

Table 186. Chong Kun Dang Pharmaceutical Corp Business Overview

Table 187. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product

Table 188. Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 189. Chong Kun Dang Pharmaceutical Corp Recent Developments

Table 190. Chugai Pharmaceutical Co Ltd Company Details

Table 191. Chugai Pharmaceutical Co Ltd Business Overview

Table 192. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product

Table 193. Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 194. Chugai Pharmaceutical Co Ltd Recent Developments

Table 195. CJ HealthCare Corp Company Details

Table 196. CJ HealthCare Corp Business Overview

Table 197. CJ HealthCare Corp Blood Pressure Disorders Drug Product

Table 198. CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 199. CJ HealthCare Corp Recent Developments

Table 200. Complexa Inc Company Details

Table 201. Complexa Inc Business Overview

Table 202. Complexa Inc Blood Pressure Disorders Drug Product

Table 203. Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 204. Complexa Inc Recent Developments

Table 205. Corion Biotech Srl Company Details

Table 206. Corion Biotech Srl Business Overview

Table 207. Corion Biotech Srl Blood Pressure Disorders Drug Product

Table 208. Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2019-2024) & (US$ Million)

Table 209. Corion Biotech Srl Recent Developments

Table 210. Research Programs/Design for This Report

Table 211. Key Data Information from Secondary Sources

Table 212. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Blood Pressure Disorders Drug Market Share by Type: 2023 VS 2030

Figure 3. Diuretics Features

Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features

Figure 5. Angiotensin Receptor Blockers (ARBs) Features

Figure 6. Others Features

Figure 7. Global Blood Pressure Disorders Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Blood Pressure Disorders Drug Market Share by Application: 2023 VS 2030

Figure 9. Hypertension Case Studies

Figure 10. Hypotension Case Studies

Figure 11. Pulmonary Hypertension Case Studies

Figure 12. Blood Pressure Disorders Drug Report Years Considered

Figure 13. Global Blood Pressure Disorders Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Blood Pressure Disorders Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Blood Pressure Disorders Drug Market Share by Region: 2023 VS 2030

Figure 16. Global Blood Pressure Disorders Drug Market Share by Players in 2023

Figure 17. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Pressure Disorders Drug as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Blood Pressure Disorders Drug Revenue in 2023

Figure 19. North America Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Blood Pressure Disorders Drug Market Share by Type (2019-2030)

Figure 21. North America Blood Pressure Disorders Drug Market Share by Application (2019-2030)

Figure 22. North America Blood Pressure Disorders Drug Market Share by Country (2019-2030)

Figure 23. United States Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Blood Pressure Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Blood Pressure Disorders Drug Market Share by Type (2019-2030)

Figure 27. Europe Blood Pressure Disorders Drug Market Share by Application (2019-2030)

Figure 28. Europe Blood Pressure Disorders Drug Market Share by Country (2019-2030)

Figure 29. Germany Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Blood Pressure Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Blood Pressure Disorders Drug Market Share by Type (2019-2030)

Figure 37. China Blood Pressure Disorders Drug Market Share by Application (2019-2030)

Figure 38. Asia Blood Pressure Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Blood Pressure Disorders Drug Market Share by Type (2019-2030)

Figure 40. Asia Blood Pressure Disorders Drug Market Share by Application (2019-2030)

Figure 41. Asia Blood Pressure Disorders Drug Market Share by Region (2019-2030)

Figure 42. Japan Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Blood Pressure Disorders Drug Market Share by Country (2019-2030)

Figure 52. Brazil Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Blood Pressure Disorders Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. A1M Pharma AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 59. Acceleron Pharma Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 60. Ache Laboratorios Farmaceuticos SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 61. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 62. Aerogen Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 63. Anavex Life Sciences Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 64. AnGes Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 65. Arena Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 66. Ascendia Pharmaceuticals LLC Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 67. Ascendis Pharma A/S Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 68. AVEO Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 69. Bayer AG Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 70. Bial - Portela & Ca SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 71. Bioblue Technologies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 72. Biogen Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 73. Biolab Farmaceutica Ltda Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 74. BioRestorative Therapies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 75. Boryung Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 76. Bristol-Myers Squibb Co Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 77. Camurus AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 78. Capricor Therapeutics Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 79. Celsion Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 80. Celtaxsys Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 81. Chiesi Farmaceutici SpA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 82. Chong Kun Dang Pharmaceutical Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 83. Chugai Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 84. CJ HealthCare Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 85. Complexa Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 86. Corion Biotech Srl Revenue Growth Rate in Blood Pressure Disorders Drug Business (2019-2024)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Mental Health Technology Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Benign Prostatic Hyperplasia Treatment Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Nasal Polyps Treatment Market Insights Forecast to 2030

Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030

Global Systemic Inflammatory Response Syndrome Treatment Market Insights Forecast to 2030

Global Subhealth Assessment and Intervention Market Insights Forecast to 2030

Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2030

Global Psychiatry EMR Software Market Insights Forecast to 2030

Global Mental Health Care Software and Services Market Insights Forecast to 2030

Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030

Global Angioedema Treatment Market Insights Forecast to 2030

Global Stroke Centers Market Insights Forecast to 2030

Global Acute Agitation and Aggression Treatment Market Insights Forecast to 2030

Global H2 Antagonist Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-33P8693

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Invasive Blood Pressure Transducer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8B18422

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Invasive Blood Pressure Transducer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30A17966

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Home Automated External Defibrillator Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10Y19630

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Blood Pressure Disorders Drug Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-5U6054

Global Blood Pressure Disorders Drug Market Insights, Forecast to 2030

FEATURED COMPANIES

Blood Pressure Disorders Drug Market Size

Blood Pressure Disorders Drug Market

Scope of Blood Pressure Disorders Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Blood Pressure Disorders Drug Market report?

What are the Application segmentation covered in the Blood Pressure Disorders Drug Market report?

What are the Type segmentation covered in the Blood Pressure Disorders Drug Market report?

FEATURED COMPANIES

RELATED REPORTS